DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

59.63 -0.07 (-0.12%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $59.63 -0.12%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.75
Previous Close $59.70
Daily Range $58.99 - $60.06
52-Week Range $51.82 - $70.87
Market Cap $99.5B
P/E Ratio 29.70
Dividend (Yield) $1.52 (2.5%)
Ex-Dividend Date
Dividend Pay Date
12/30/15
02/01/16
Volume 7,129,501
Average Daily Volume 7,599,897
Current FY EPS $1.89

Sector

Healthcare

Industry

Drug Makers

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary

3 Potential Blockbusters Moving the Needle for Big Pharma in 2016

These pharmas have some recently approved drugs that could singlehandedly boost total sales this year.

Waging War on the Greatest Cancer Myth of All

This common cancer belief lives on, but that doesn't mean it's true.

Upcoming Events - Bayer's Lung Cancer Effort And Apricus And Zealand Try Again

Why Achillion Pharmaceuticals Shares Crashed 37% in January

Investors continue to sell off the once-promising developer of hepatitis C drugs.

My Newest Sweet REIT Purchases: Welltower And National Health Investors

Is Big Pharma Hinting At A SMID-Cap Biotech Rally?

Why Medivation, Inc. Shares Crashed 32% in January

A delay to a key clinical trial weighed on shares last month.

Emotional Investing Deflates Exelixis, Inc. in January

Exelixis' fundamental thesis gets a lift in January, but that doesn't matter to skittish investors.

3 Numbers That Matter When Merck Reports Its Fourth-Quarter Results

These three figures may prove far more important than Merck's fourth-quarter and full-year headline results.

Will 2016 Be Merck & Co. Inc.'s Best Year Yet?

Merck shareholders have plenty to look forward to in 2016, but is that enough to make this Merck's best year yet?

See More BMY News...

BMY's Top Competitors

BMY $59.63 (-0.12%)
Current stock: BMY
JNJ $100.54 (-3.23%)
Current stock: JNJ
NVS $74.33 (-0.97%)
Current stock: NVS
RHHBY $31.69 (-1.18%)
Current stock: RHHBY